Filing Details
- Accession Number:
- 0001209191-19-028227
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-08 16:20:41
- Reporting Period:
- 2019-05-08
- Accepted Time:
- 2019-05-08 16:20:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1108109 | Community Health Systems Inc | CYH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1018660 | T Wayne Smith | 4000 Meridian Boulevard Franklin TN 37067 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-08 | 6,551 | $3.47 | 2,636,482 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 206,842 | Indirect | by 2009 WTS Irrevocable Trust Dated 2/27/09 |
| Common Stock | 481,721 | Indirect | WAC LLC |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | $30.32 | 2011-02-24 | 2020-02-23 | 50,000 | 50,000 | Direct |
| Common Stock | Stock Options (Right to Buy) | $34.38 | 2012-02-23 | 2021-02-22 | 50,000 | 50,000 | Direct |
| Common Stock | Stock Options (Right to Buy) | $17.49 | 2013-02-16 | 2022-02-15 | 40,000 | 40,000 | Direct |
| Common Stock | Stock Options (Right to Buy) | $4.99 | 2020-03-01 | 2029-02-28 | 78,750 | 78,750 | Direct |
| Common Stock | Performance Based Restricted | $0.00 | 75,000 | 75,000 | Direct | ||
| Common Stock | Performance Based Restricted | $0.00 | 105,000 | 105,000 | Direct | ||
| Common Stock | Performance Based Restricted | $0.00 | 157,500 | 157,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-02-23 | 50,000 | 50,000 | Direct |
| 2021-02-22 | 50,000 | 50,000 | Direct |
| 2022-02-15 | 40,000 | 40,000 | Direct |
| 2029-02-28 | 78,750 | 78,750 | Direct |
| 75,000 | 75,000 | Direct | |
| 105,000 | 105,000 | Direct | |
| 157,500 | 157,500 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/8/2019 at prices ranging from $3.36 to $3.575, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Together with shares purchased by the reporting person on 5/3/2019, 5/6/2019 and 5/7/2019, which purchases were reported in the Form 4 filed for the reporting person on 5/7/2019, the reporting person has purchased a total of 1,000,000 shares of the Issuer's common stock since 5/3/2019 at a weighted average purchase price for all such purchases of $3.368.
- The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2017 and 12/31/2019 (the "2017-2019 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2017-2019 Performance Period.
- The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2018-2020 Performance Period.
- The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.
Billionaire Hedge Funds
